HealthIs the US seeing a turning point in obesity rates?

After decades of rising obesity rates, several US data sources now suggest a possible decline. Prescriptions for GLP-1 drugs including Ozempic, Wegovy and Zepbound more than quadrupled from 2021 to early 2026. Researchers say the medicines may be contributing, but there is no definitive proof of a causal link; lifestyle changes and greater attention to weight management may also matter. One projection still forecasts rates rising through 2035.

US obesityweight-loss drugsGLP-1public health

DDW★★★☆☆2026-08-23 09:20Original